The injection of ID3‐overexpressing BMDMs into mouse tumor models resulted in a significant inhibition of tumor growth and metastasis, accompanied by enhanced recruitment and activation of NK and CD8+ T cells across multiple mice tumor models. Here, CD8A is linked to neoplasm.